Company Filing History:
Years Active: 2022-2025
Title: Arne Von Bonin: Innovator in Vaccine Development
Introduction
Arne Von Bonin is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of vaccine development, holding a total of 4 patents. His work focuses on synthetic saccharides that play a crucial role in preventing and treating bacterial diseases.
Latest Patents
Among his latest patents is a stable vaccine against specific diseases. This invention relates to a synthetic saccharide of general formula (I) that is associated with PS-II cell-surface polysaccharides and their conjugates. The synthetic saccharide and the pharmaceutical compositions containing it are useful for the prevention and treatment of diseases. Additionally, this synthetic saccharide serves as a marker in immunological assays for detecting antibodies against bacteria. Another significant patent involves a vaccine against Klebsiella pneumoniae, which also utilizes a synthetic saccharide of general formula (I) related to various serotypes and carbapenem-resistant O-polysaccharides. This invention similarly aids in the prevention and treatment of associated diseases and serves as a marker in immunological assays.
Career Highlights
Arne Von Bonin is currently employed at Idorsia Pharmaceuticals Ltd., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing vaccine technology and improving public health outcomes.
Collaborations
He collaborates with talented coworkers, including Bopanna Monnanda and Claney Lebev Pereira, contributing to a dynamic research environment.
Conclusion
Arne Von Bonin's contributions to vaccine development through his innovative patents highlight his role as a key figure in the fight against bacterial diseases. His ongoing work at Idorsia Pharmaceuticals Ltd. continues to pave the way for advancements in medical science.